前胡가 Bleomycin에 의한 폐 섬유화에 미치는 영향

키워드

참고문헌 (44)

1. American Thoracic Society, "Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society(ATS), and the European Respiratory Society(ERS)", Am J Respir Crit Care Med, 165, pp.277~304 (2002)
2. British Thoracic Society: Standards of Care Committee, "The diagnosis, assessment and treatment of diffuse parenchymal lung disease in adults", Thorax, 54(1), pp.S1S30~ (1999)
3. Gross TJ, "Idiopathic pulmonary fibrosis", N Engl J Med, 345, pp.517~525 (2001)
4. 박주헌, "통상성 간질성 폐렴의 임상경과", 대한 결핵 및 호흡기 질환, 49(5), pp.601~613 (2000)
5. 김한겸, "특발성 간질성 폐렴의 분류 및 병리학적 소견", 결핵 및 호흡기질환, 54(2), pp.145~166 (2003), 대한결핵및호흡기학회
6. Alvarez-Sala R, "Idiopathic pulmonary fibrosis: new diagnosis and therapethetic perspective", An Med Interna, 10(7), pp.355~360 (1993)
7. 武維屛, "中西醫臨床呼吸病學", pp.217~219 (1998), 中國中醫藥出版社
8. 張天嵩, "補氣通肺湯治療特發性肺纖維化12例", 浙江中醫雜誌, 34(2), pp.54~55 (1999)
9. 崔紅生, "肺間質纖維化從絡病辨治探析", Journal of Traditional Chinese Medicine, 44(12), pp.946~947 (2003)
10. 전국한의과 대학 교수, "본초학", pp.458~459 (2000), 영림사
11. 노홍표, "前胡藥鍼이 Ovalbumin-induced Asthma Mouse Model에 미치는 영향", 대한침구학회지, 22(6), pp.1~15 (2005), 대한침구학회
12. Xi SC, "Experimental studies on inhibitory effects of radix Peucedani on hypoxic pulmonary hypertension in rats", Zhongguo Zhong Xi Yi Jie He Za Zhi, 16(4), pp.218~220 (1996)
13. 金銀花가 Bleomycin에 의한 肺纖維化에 미치는 影響, "이재성", 경희대학교 대학원, ~ (2004)
14. 熟地黃이 Bleomycin에 의한 肺纖維化에 미치는 影響, "류한천", 경희대학교 대학원, ~ (2004)
15. 黃芪가 C57BL, "6J 생쥐의 Bleomycin유발 肺纖維化에 미치는 影響", 이경희, 2004
16. 麥門冬이 C57BL, "6J 생쥐의 Bleomycin유발 肺纖維化에 미치는 影響", 이병삼, 2004
17. 貝母가 Bleomycin에 의한 肺纖維化에 미치는 影響, "이규선", 경희대학교 대학원, ~ (2005)
18. Chang KW, "Idiopathic pulmonary fibrosis in a child", Hang Gung Med J, 26(1), pp.60~64 (2003)
19. Rigante D, "Diagnostic clues in the idiopathic pulmonary fibrosis of children", Minerva Pediatr, 56(2), pp.157~160 (2004)
20. Berkman N, "Human recombinant interferon-alpha2a and interferon-alphaA", D have different effects on bleomycin-induced lung injury, 2001, pp.68(2), 169~177
21. Laxer U, "Christensen TG, Goldstein RH, Breuer R. The effect of enoxaparin on bleomycin-induced lung injury in mice", Exp Lung Res, 25(6), pp.531~541 (1999)
22. Kremer S, "Effect of immunomodulators on bleomycin-induced lung injury", Respiration, 66(5), pp.455~462 (1999)
23. Lossos IS, "Peribronchial lymphocyte activation in bleomycin-induced lung injury", Life Sci, 63(13), pp.1183~1193 (1998)
24. Travis WD, "Idiopathic nonspecific interstitial pneumonias: prognostic significance of dellular and fibrosting patterns: survival comparison with usaual interstitial pneumonia and desquamative interstitial pneumonias", Am J Surg Pathol, 24, pp.19~33 (2000)
25. Johnson MA, "Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis", Thorax, 44(4), pp.280~288 (1989)
26. 陳永輝, "傷見呼吸係疾患中西醫結合診斷與治療", pp.243~251 (1998), 中國醫藥科技出版社
27. 張偉, "中西醫結合呼吸病診斷學", pp.211~224 (1995), 中國南海出版公司
28. 강소신의학원, "중약대사전", pp.4874~4879 (1998), 도서출판 정담
29. 이성우, "전호의 항암활성성분 anthricin", 약학논문집, 8, pp.72~ (1993)
30. Wu JY, "Reversal of multidrug resistance in cancer cells by pyranocoumarins isolated from Radix Peucedani", Eur J Pharmacol, 473(1), pp.9~17 (2003)
31. Lee SO, "Antidiabetic coumarin and cyclitol compounds from Peucedanum japonicum", Arch Pharm Res, 27(12), pp.1207~1210 (2004)
32. Souhir B, "Deglycosylated bleomycin induces apoptosis in lymphoma cell via c-jun NH(2)-terminal kinase but not reactive oxygen species", Biochem Pharmacol, 2(2), pp.167~177 (2007)
33. Yoshimura K, "Pathogenesis of idiopathethic interstitial pneumonias", Idiopathic pulmonary fibrosis: celluar and molecular biology of the disease, 1993, pp.31, 20~31
34. Wallick SC, "Immunoregulatery role of TGF-β in development of killer cells: Comparison of active and latent TGF-β1", J Exp Med, 172, pp.1777~1784 (1990)
35. Giri SN, "Biochemical and structural alterations of hamster lungs in response to intratracheal administration of bleomycin", Exp Mol Pathol, 33(1), pp.1~14 (1980)
36. Kanematsu T, "Clubbing of the fingers and smooth-muscle proliferation in fibrotic changes in the lung in patients with Idiopathic pulmonary fibrosis", Chest, 105(2), pp.339~342 (1994)
37. Keogh BA, "Alveolitis: the key to the interstitial lung disorders", Thorax, 37, pp.1~10 (1982)
38. Burkhardt A, "Alveolitis and collapse in the pathogenesis of pulmonary fibrosis", Am Rev Respir Dis, 140(2), pp.513~524 (1989)
39. Crystal RG, "Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract", N Engl J Med, 310(4), pp.235~244 (1984)
40. Campbell EJ, "Extracellular matrix injury during lung inflammation", Chest, 92(1), pp.161~167 (1987)
41. Gadek JE, "Collagenase in the lower respiratory tract of patients with idiopathic pulmonary fibrosis", N Engl J Med, 301(14), pp.737~742 (1979)
42. Shindoh Y, "Cellular analysis in bronchoalveolar lavage fluids in infiltrative and fibrotic stages of idiopathic pulmonary fibrosis", Tohoku J Exp Med, 149(1), pp.47~60 (1986)
43. Selman M, "American Thoracic Society; European Respiratory Society; American College of Chest Physicians. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy", Ann Intern Med, 134(2), pp.136~151 (2001)
44. 어수택, "폐 섬유화증의 병인 및 병태 생리", 결핵 및 호흡기질환, 54(2), pp.167~177 (2003), 대한결핵및호흡기학회

관련 논문AI추천